Translation-Focused Approaches to GPCR Drug Discovery for Cognitive Impairments Associated with Schizophrenia

[Image: see text] There are no effective therapeutics for cognitive impairments associated with schizophrenia (CIAS), which includes deficits in executive functions (working memory and cognitive flexibility) and episodic memory. Compounds that have entered clinical trials are inadequate in terms of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:ACS Pharmacol Transl Sci
Egile Nagusiak: Hatzipantelis, Cassandra J., Langiu, Monica, Vandekolk, Teresa H., Pierce, Tracie L., Nithianantharajah, Jess, Stewart, Gregory D., Langmead, Christopher J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Chemical Society 2020
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7737210/
https://ncbi.nlm.nih.gov/pubmed/33344888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.0c00117
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak